The Barrx™ radiofrequency ablation system is used to treat Barrett's esophagus (BE) patients by eradicating Barrett's epithelium.
The Barrx™ radiofrequency ablation system is designed to precisely eradicate the Barrett's epithelium. Barrett's esophagus patients with low-grade dyplasia treated with RFA have a substantial reduction in progression compared to patients who undergo surveillance alone. The Barrx™ radiofrequency ablation system includes the Barrx™ flex RFA energy generator and a family of ablation catheters.